Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua New Tactics for Bladder Cancer After decades without treatment advances, options for patients with bladder cancer are now more numerous. by Kendall K. Morgan Survivor Profile Hope and Endurance Bladder cancer survivor Randy Layne and his wife, Ellen, faced his diagnosis, treatment and recovery together. by Martha Irvine Yesterday & Today Who Loves Ya, Baby? Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference. by Jocelyn Selim Cancer Talk The Mental Toll of a Cancer Diagnosis New studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk. by Pamela Rafalow Grossman Access to Health Insurance Key to Disparities in Cancer Outcomes As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared. by Jon Kelvey T Cells Key to COVID-19 Vaccination Efforts Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation. by Thomas Celona Exploring Amino Acids’ Impact on Tumor Growth Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression. by Thomas Celona More Posts